BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 312165 CCc1ncc(Cc2ccc3cccc(O)c3n2)c2cc(OC)c(OC)cc12 InChI=1S/C23H22N2O3/c1-4-19-18-12-22(28-3)21(27-2)11-17(18)15(13-24-19)10-16-9-8-14-6-5-7-20(26)23(14)25-16/h5-9,11-13,26H,4,10H2,1-3H3 WBJAKXOIBNITGN-UHFFFAOYSA-N 194401 US9200016, 83::US9902710, Compound 83 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 439 7.4 37.00 C US Patent 10.7270/Q2ZC81PH aid1801958 US9200016 Leblond, B; Taverne, T; Chauvignac, C; Beausoleil, E; Casagrande, A; Desire, L; Pando, MP; Donello, JE; Yang, R Allergan Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=194401&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 71779122 318123598 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 312166 CCc1ncc(Cc2ccc3cccc(NC(=O)C(N)=O)c3n2)c2cc(OC)c(OC)cc12 InChI=1S/C25H24N4O4/c1-4-19-18-12-22(33-3)21(32-2)11-17(18)15(13-27-19)10-16-9-8-14-6-5-7-20(23(14)28-16)29-25(31)24(26)30/h5-9,11-13H,4,10H2,1-3H3,(H2,26,30)(H,29,31) XUCXEJHCWUEFBU-UHFFFAOYSA-N 194411 US9200016, 93::US9902710, Compound 93 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 398 7.4 37.00 C US Patent 10.7270/Q2ZC81PH aid1801958 US9200016 Leblond, B; Taverne, T; Chauvignac, C; Beausoleil, E; Casagrande, A; Desire, L; Pando, MP; Donello, JE; Yang, R Allergan Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=194411&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 74539811 318123608 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 312167 CCCc1ncc(Cc2cnc3ccc(O)c(c3c2)C(F)(F)F)c2cc(OC)c(OC)cc12 InChI=1S/C25H23F3N2O3/c1-4-5-19-17-11-23(33-3)22(32-2)10-16(17)15(13-30-19)8-14-9-18-20(29-12-14)6-7-21(31)24(18)25(26,27)28/h6-7,9-13,31H,4-5,8H2,1-3H3 MWLFLDJUMFIHDC-UHFFFAOYSA-N 194480 US9200016, 162::US9902710, Compound 162 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 232 7.4 37.00 C US Patent 10.7270/Q2ZC81PH aid1801958 US9200016 Leblond, B; Taverne, T; Chauvignac, C; Beausoleil, E; Casagrande, A; Desire, L; Pando, MP; Donello, JE; Yang, R Allergan Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=194480&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118115584 318123675 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 312168 COCc1ncc(Cc2cnc3ccc(O)c(c3c2)C(F)(F)F)c2cc(OC)c(OC)cc12 InChI=1S/C24H21F3N2O4/c1-31-12-19-16-9-22(33-3)21(32-2)8-15(16)14(11-29-19)6-13-7-17-18(28-10-13)4-5-20(30)23(17)24(25,26)27/h4-5,7-11,30H,6,12H2,1-3H3 AQCSZBJZPWCJBX-UHFFFAOYSA-N 194487 US9200016, 169::US9902710, Compound 169 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 194 7.4 37.00 C US Patent 10.7270/Q2ZC81PH aid1801958 US9200016 Leblond, B; Taverne, T; Chauvignac, C; Beausoleil, E; Casagrande, A; Desire, L; Pando, MP; Donello, JE; Yang, R Allergan Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=194487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=194487&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 90117656 318123682 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543564 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2 OUXBYUBGWJQGHZ-UHFFFAOYSA-N 285528 Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 130 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863076 378169167 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543565 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2 OUXBYUBGWJQGHZ-UHFFFAOYSA-N 285528 Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 10300 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863076 378169167 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543568 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22) YOCIPGYKDZCTFU-UHFFFAOYSA-N 285529 3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 27.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863067 378169168 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543569 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22) YOCIPGYKDZCTFU-UHFFFAOYSA-N 285529 3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4340 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863067 378169168 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543572 COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3 SCHCQOLPISHKOS-UHFFFAOYSA-N 285530 Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 51.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863063 378169169 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543573 COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3 SCHCQOLPISHKOS-UHFFFAOYSA-N 285530 Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2410 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863063 378169169 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543576 COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22) SDZFOFNADNADKA-UHFFFAOYSA-N 285531 N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 561 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863072 378169170 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543577 COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22) SDZFOFNADNADKA-UHFFFAOYSA-N 285531 N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >27100 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863072 378169170 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543580 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23) YDADFGXXCHDXFC-UHFFFAOYSA-N 285532 3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 208 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863059 378169171 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543581 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23) YDADFGXXCHDXFC-UHFFFAOYSA-N 285532 3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >26600 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863059 378169171 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543584 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1 InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24) KZFDLYSKEWBCTB-UHFFFAOYSA-N 285533 N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 326 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863057 378169172 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543585 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1 InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24) KZFDLYSKEWBCTB-UHFFFAOYSA-N 285533 N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4890 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863057 378169172 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543588 Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1 InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26) LSCITVBMOOTYOS-UHFFFAOYSA-N 285534 3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2.35 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863065 378169173 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543589 Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1 InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26) LSCITVBMOOTYOS-UHFFFAOYSA-N 285534 3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 34.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863065 378169173 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543592 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1 InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2 AAWHVDHSXWEWJR-UHFFFAOYSA-N 285535 Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 64.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863058 378169174 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543593 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1 InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2 AAWHVDHSXWEWJR-UHFFFAOYSA-N 285535 Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5440 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863058 378169174 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543596 Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24) IJGCWHSMOTWWLO-UHFFFAOYSA-N 285536 3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 40.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863077 378169175 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543597 Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24) IJGCWHSMOTWWLO-UHFFFAOYSA-N 285536 3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1490 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118863077 378169175 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543600 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23) VPDYRGHPOFWFHI-UHFFFAOYSA-N 285537 3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6.84 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875363 378169176 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543601 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23) VPDYRGHPOFWFHI-UHFFFAOYSA-N 285537 3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 590 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875363 378169176 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543603 Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23) HJVCDCPLKNQXFO-UHFFFAOYSA-N 285538 N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 334 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700151 378169177 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543606 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) SRRULVNTICTTGE-UHFFFAOYSA-N 285539 3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 89.6 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875408 378169178 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543607 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23) SRRULVNTICTTGE-UHFFFAOYSA-N 285539 3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5220 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875408 378169178 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543610 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 IVSBLXFZMFGIAK-UHFFFAOYSA-N 285540 US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 17.3 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700157 378169179 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543611 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 IVSBLXFZMFGIAK-UHFFFAOYSA-N 285540 US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 669 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700157 378169179 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543614 Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22) BAWGMUZVOXOKPF-UHFFFAOYSA-N 285541 3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 108 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700152 378169180 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543615 Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22) BAWGMUZVOXOKPF-UHFFFAOYSA-N 285541 3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >8010 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700152 378169180 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543618 Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2 QELHEVBSVCAUHV-UHFFFAOYSA-N 285542 US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 421 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 125474237 378169181 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543619 Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2 QELHEVBSVCAUHV-UHFFFAOYSA-N 285542 US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >23700 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 125474237 378169181 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543621 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1 InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2 WFFUVTXNYNORQT-UHFFFAOYSA-N 285543 US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >27500 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875381 378169182 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543624 Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25) SAWDLJNAAJBRMX-UHFFFAOYSA-N 285544 3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 216 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875411 378169183 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543625 Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25) SAWDLJNAAJBRMX-UHFFFAOYSA-N 285544 3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >18200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875411 378169183 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543628 Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3 GGBPMJVCUHMAJB-UHFFFAOYSA-N 285545 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 147 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700154 378169184 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543629 Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3 GGBPMJVCUHMAJB-UHFFFAOYSA-N 285545 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 8200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700154 378169184 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543632 Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25) PMXQBXHVHKGVCD-UHFFFAOYSA-N 285546 3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 98.4 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875364 378169185 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543633 Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25) PMXQBXHVHKGVCD-UHFFFAOYSA-N 285546 3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 645 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875364 378169185 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543636 Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3 NJCCFDZQRIVPQK-UHFFFAOYSA-N 285547 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 74.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126683777 378169186 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543637 Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3 NJCCFDZQRIVPQK-UHFFFAOYSA-N 285547 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 490 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126683777 378169186 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543640 CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3 VTRNMYGATDHWOK-UHFFFAOYSA-N 285548 3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 170 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700156 378169187 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543641 CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3 VTRNMYGATDHWOK-UHFFFAOYSA-N 285548 3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >12300 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700156 378169187 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543644 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1 InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24) XWBNVRGWNULCLK-UHFFFAOYSA-N 285549 N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 71.2 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875403 378169188 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543645 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1 InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24) XWBNVRGWNULCLK-UHFFFAOYSA-N 285549 N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1890 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875403 378169188 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543648 Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2 COQGBMKNVJUVAB-UHFFFAOYSA-N 285550 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 45.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700158 378169189 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543649 Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2 COQGBMKNVJUVAB-UHFFFAOYSA-N 285550 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4130 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700158 378169189 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543652 Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2 GLYPDLWNQYDRTQ-UHFFFAOYSA-N 285551 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 59.7 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700159 378169190 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543653 Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2 GLYPDLWNQYDRTQ-UHFFFAOYSA-N 285551 4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >2150 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700159 378169190 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543656 CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22) APQCTKWSIMEXKR-UHFFFAOYSA-N 285552 3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 150 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875410 378169191 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543657 CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22) APQCTKWSIMEXKR-UHFFFAOYSA-N 285552 3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4970 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875410 378169191 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543660 CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22) VDPHNQHKTFMQPH-UHFFFAOYSA-N 285553 3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 111 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875372 378169192 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543661 CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22) VDPHNQHKTFMQPH-UHFFFAOYSA-N 285553 3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3800 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875372 378169192 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543664 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1 InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2 VGOMARAKBZMHJT-UHFFFAOYSA-N 285554 US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 768 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875398 378169193 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543665 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1 InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2 VGOMARAKBZMHJT-UHFFFAOYSA-N 285554 US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5620 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875398 378169193 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543668 CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1 InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23) GXYHCJBIWBLNEK-UHFFFAOYSA-N 285555 3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 49.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875386 378169194 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543669 CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1 InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23) GXYHCJBIWBLNEK-UHFFFAOYSA-N 285555 3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 393 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875386 378169194 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543672 CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23) ZOPYTZDTLDQKKZ-UHFFFAOYSA-N 285556 3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 13.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875384 378169195 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543673 CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23) ZOPYTZDTLDQKKZ-UHFFFAOYSA-N 285556 3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 409 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875384 378169195 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543676 CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23) VSOPHYORBVNBMU-UHFFFAOYSA-N 285557 3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 24.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700166 378169196 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543677 CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23) VSOPHYORBVNBMU-UHFFFAOYSA-N 285557 3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4000 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700166 378169196 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543680 COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3 WJDDXTCEGQNYBD-UHFFFAOYSA-N 285558 US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5810 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700165 378169197 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543681 COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3 WJDDXTCEGQNYBD-UHFFFAOYSA-N 285558 US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >26200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700165 378169197 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543684 CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3 YRYSHRMLXGRWSA-UHFFFAOYSA-N 285559 3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 469 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875382 378169198 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543685 CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3 YRYSHRMLXGRWSA-UHFFFAOYSA-N 285559 3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875382 378169198 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543688 CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23) DJBROLKNQFDUKD-UHFFFAOYSA-N 285560 3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 127 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700164 378169199 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543689 CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23) DJBROLKNQFDUKD-UHFFFAOYSA-N 285560 3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2330 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700164 378169199 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543692 CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1 InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23) SRLHMGKYTUHFKW-UHFFFAOYSA-N 285561 3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 47.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875377 378169200 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543693 CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1 InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23) SRLHMGKYTUHFKW-UHFFFAOYSA-N 285561 3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2110 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875377 378169200 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543696 Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23) JXDYJNOWRSRYDW-UHFFFAOYSA-N 285562 3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 37.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875400 378169201 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543697 Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23) JXDYJNOWRSRYDW-UHFFFAOYSA-N 285562 3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1220 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875400 378169201 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543700 Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22) ZQTGMZNEQOGOQC-UHFFFAOYSA-N 285563 3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 21.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875416 378169202 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543701 Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22) ZQTGMZNEQOGOQC-UHFFFAOYSA-N 285563 3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 254 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875416 378169202 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543704 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2 InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24) COONGBDOJFYLER-UHFFFAOYSA-N 285564 N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 161 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700169 378169203 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543705 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2 InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24) COONGBDOJFYLER-UHFFFAOYSA-N 285564 N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2570 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700169 378169203 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543707 O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1 InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23) XQQOHFBKZLHZIC-UHFFFAOYSA-N 285565 N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 11200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700168 378169204 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543710 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1 InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23) WBVHJGBFCGWOMH-UHFFFAOYSA-N 285566 3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 67.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700170 378169205 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543711 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1 InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23) WBVHJGBFCGWOMH-UHFFFAOYSA-N 285566 3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3820 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700170 378169205 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543714 Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23) WMBGBRRUSMUDQB-UHFFFAOYSA-N 285567 3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 58.1 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875401 378169206 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543715 Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23) WMBGBRRUSMUDQB-UHFFFAOYSA-N 285567 3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 9020 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875401 378169206 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543718 Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) XXAZCHDKOQBDMG-UHFFFAOYSA-N 285568 N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 16.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700171 378169207 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543719 Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23) XXAZCHDKOQBDMG-UHFFFAOYSA-N 285568 N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 467 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700171 378169207 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543722 FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25) QJYXPHGWTACNMO-UHFFFAOYSA-N 285569 N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 357 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875412 378169208 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543723 FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25) QJYXPHGWTACNMO-UHFFFAOYSA-N 285569 N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >12200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875412 378169208 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543725 FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2 GXXYJNKWPOFUGD-UHFFFAOYSA-N 285570 US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >16900 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875413 378169209 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543727 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25) LLYJCFVFPOZAJN-UHFFFAOYSA-N 285571 3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 320 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875387 378169210 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543730 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1 QSRJUMJDYNOQBS-NWDGAFQWSA-N 285572 3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 11.7 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700172 378169211 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543731 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1 QSRJUMJDYNOQBS-NWDGAFQWSA-N 285572 3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 159 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700172 378169211 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543734 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1 LROCAZWHWFXPFN-NWDGAFQWSA-N 285573 3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 39.3 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700173 378169212 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543735 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1 LROCAZWHWFXPFN-NWDGAFQWSA-N 285573 3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 971 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700173 378169212 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543738 Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2 UGUNGNPFDJUJNI-UHFFFAOYSA-N 285574 US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 23.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700174 378169213 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543739 Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2 UGUNGNPFDJUJNI-UHFFFAOYSA-N 285574 US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 334 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700174 378169213 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543742 CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1 InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22) XXRCLGJTXPMSDT-UHFFFAOYSA-N 285575 3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 212 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875389 378169214 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543743 CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1 InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22) XXRCLGJTXPMSDT-UHFFFAOYSA-N 285575 3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >7670 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875389 378169214 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543746 Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 MBBSPQBGJJWYLF-UHFFFAOYSA-N 285576 US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 19.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875405 378169215 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543747 Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 MBBSPQBGJJWYLF-UHFFFAOYSA-N 285576 US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 535 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875405 378169215 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543750 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1 InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2 HVVGNLROCIOALI-UHFFFAOYSA-N 285577 US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 235 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700175 378169216 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543751 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1 InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2 HVVGNLROCIOALI-UHFFFAOYSA-N 285577 US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3140 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700175 378169216 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543753 Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 TZEKFEDRWKCDSN-UHFFFAOYSA-N 285578 US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2810 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700177 378169217 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543756 Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 FRHMLRQQIOCJKU-UHFFFAOYSA-N 285579 US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 113 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700176 378169218 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543757 Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 FRHMLRQQIOCJKU-UHFFFAOYSA-N 285579 US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5510 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700176 378169218 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543760 Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3 CTXZJNXACMKAGH-UHFFFAOYSA-N 285580 US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 153 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700178 378169219 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543761 Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3 CTXZJNXACMKAGH-UHFFFAOYSA-N 285580 US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3110 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700178 378169219 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543764 Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 BDIWEEUPORVMSZ-UHFFFAOYSA-N 285581 US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 136 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700179 378169220 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543765 Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 BDIWEEUPORVMSZ-UHFFFAOYSA-N 285581 US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >20000 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700179 378169220 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543768 COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 GGBSVVWNJGUOLN-UHFFFAOYSA-N 285582 US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >1550 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700180 378169221 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543769 COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 GGBSVVWNJGUOLN-UHFFFAOYSA-N 285582 US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >20900 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700180 378169221 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543772 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 KDPKDOHAJHCGSZ-UHFFFAOYSA-N 285583 US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 84.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700181 378169222 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543773 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 KDPKDOHAJHCGSZ-UHFFFAOYSA-N 285583 US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3930 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700181 378169222 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543775 Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28) AQSPRZIQVZXKMZ-UHFFFAOYSA-N 285584 3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >21800 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700182 378169223 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543777 Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1 InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24) WFHCBSIMFWEHOP-UHFFFAOYSA-N 285585 3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 831 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700183 378169224 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543779 Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1 InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25) KUCAVVPPPHKSFZ-UHFFFAOYSA-N 285586 3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 749 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700184 378169225 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543782 FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2 LLONFBHYVKPZCK-UHFFFAOYSA-N 285587 US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 287 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700185 378169226 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543783 FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2 LLONFBHYVKPZCK-UHFFFAOYSA-N 285587 US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >4930 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700185 378169226 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543786 FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2 PKGAXGNVVMHTJZ-UHFFFAOYSA-N 285588 US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 126 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700186 378169227 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543787 FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2 PKGAXGNVVMHTJZ-UHFFFAOYSA-N 285588 US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1930 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700186 378169227 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543789 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1 InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2 BGLGXXOVOLTBJL-UHFFFAOYSA-N 285589 US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 11000 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700187 378169228 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543791 CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3 QERGAMABSQIOLR-UHFFFAOYSA-N 285590 1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 394 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875365 378169229 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543793 Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 COVWSPFRFUFHGD-UHFFFAOYSA-N 285591 US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 844 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700189 378169230 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543795 Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1 InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 HDPIQIDAUQGIBP-UHFFFAOYSA-N 285592 US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3720 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700188 378169231 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543797 Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3 FQEXMVRMBJXJHA-UHFFFAOYSA-N 285593 US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3390 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700190 378169232 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543799 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1 InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2 KQJWGLFCGGXBHN-UHFFFAOYSA-N 285594 US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2260 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875392 378169233 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543802 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1 OPBIZTGCIJZSGG-NWDGAFQWSA-N 285595 3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 25.1 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700194 378169234 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543803 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1 OPBIZTGCIJZSGG-NWDGAFQWSA-N 285595 3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2620 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700194 378169234 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543805 F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1 InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1 ZHXHNZIKCBDMKP-WDEREUQCSA-N 285596 3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3330 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700193 378169235 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543808 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1 XIVVDTJZCTVMFP-QWHCGFSZSA-N 285597 3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 90.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700199 378169236 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543809 Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1 XIVVDTJZCTVMFP-QWHCGFSZSA-N 285597 3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5760 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700199 378169236 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543812 Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1 GAGSQLMTGCAMOG-QWHCGFSZSA-N 285598 3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2.00 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700196 378169237 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543813 Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1 GAGSQLMTGCAMOG-QWHCGFSZSA-N 285598 3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 113 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700196 378169237 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543815 Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1 InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1 LTEXTCILPHUJPK-QWHCGFSZSA-N 285599 N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6590 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700195 378169238 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543818 COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 WXZZRVFNPNQGRD-UHFFFAOYSA-N 285600 US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1440 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700197 378169239 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543819 COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3 WXZZRVFNPNQGRD-UHFFFAOYSA-N 285600 US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >24700 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700197 378169239 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543821 O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1 InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2 RINAWWCARFNGLM-UHFFFAOYSA-N 285601 US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 10500 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700198 378169240 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543824 FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24) DSCLXJMGAQHPPO-UHFFFAOYSA-N 285602 N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 24.9 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875376 378169241 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543825 FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24) DSCLXJMGAQHPPO-UHFFFAOYSA-N 285602 N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 104 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875376 378169241 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543828 FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2 FGLJIZXIRLUUJT-UHFFFAOYSA-N 285603 US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 22.2 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875361 378169242 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543829 FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2 FGLJIZXIRLUUJT-UHFFFAOYSA-N 285603 US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 94.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875361 378169242 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543832 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1 InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2 AZGFYUPSXODBAO-UHFFFAOYSA-N 285607 US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 186 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700200 378169246 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543833 O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1 InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2 AZGFYUPSXODBAO-UHFFFAOYSA-N 285607 US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >16600 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700200 378169246 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543835 O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1 InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24) CWHUSRYDJYDLGV-UHFFFAOYSA-N 285608 N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 78::US10669279, Example 78::US9598421, Example 78 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6490 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875395 378169247 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543838 Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24) NOSXOAFVJDFCQR-UHFFFAOYSA-N 285609 3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 297 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875362 378169248 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543839 Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24) NOSXOAFVJDFCQR-UHFFFAOYSA-N 285609 3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >25400 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875362 378169248 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543841 Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24) AYAPJFYFCDHLKN-UHFFFAOYSA-N 285610 3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 80::US10669279, Example 80::US9598421, Example 80 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >25400 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875393 378169249 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543844 CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22) KMAXAJFXSIHYPS-UHFFFAOYSA-N 285611 3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 25.8 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875415 378169250 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543845 CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22) KMAXAJFXSIHYPS-UHFFFAOYSA-N 285611 3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 853 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875415 378169250 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543848 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1 InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25) YEUSBANVZAFKBV-UHFFFAOYSA-N 285612 3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 43.4 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875379 378169251 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543849 Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1 InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25) YEUSBANVZAFKBV-UHFFFAOYSA-N 285612 3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 56.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875379 378169251 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543852 Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 VGRIHMHLBGLHHB-UHFFFAOYSA-N 285613 US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 40.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 125474324 378169252 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543853 Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2 VGRIHMHLBGLHHB-UHFFFAOYSA-N 285613 US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 495 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 125474324 378169252 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543856 Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2 LLKDXLOAXVIBRW-UHFFFAOYSA-N 285614 US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 44.4 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875397 378169253 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543857 Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2 LLKDXLOAXVIBRW-UHFFFAOYSA-N 285614 US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 977 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875397 378169253 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543860 CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21) SNPDIBMAAUTAIH-UHFFFAOYSA-N 285615 3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 47.2 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875373 378169254 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543861 CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21) SNPDIBMAAUTAIH-UHFFFAOYSA-N 285615 3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6700 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875373 378169254 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543864 FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2 CIMWFDZKHUKERW-UHFFFAOYSA-N 285616 US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 25.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875409 378169255 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543865 FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1 InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2 CIMWFDZKHUKERW-UHFFFAOYSA-N 285616 US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 179 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875409 378169255 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543868 FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24) YCEYKGZVRQVUNW-UHFFFAOYSA-N 285617 N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 397 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875385 378169256 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543869 FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24) YCEYKGZVRQVUNW-UHFFFAOYSA-N 285617 N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6790 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875385 378169256 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543872 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1 InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23) QCUHKLBHHWHXAM-UHFFFAOYSA-N 285618 3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 136 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700202 378169257 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543873 O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1 InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23) QCUHKLBHHWHXAM-UHFFFAOYSA-N 285618 3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 10400 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700202 378169257 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543876 Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25) HWZASUIHFDZUSF-UHFFFAOYSA-N 285619 N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3760 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875367 378169258 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543877 Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25) HWZASUIHFDZUSF-UHFFFAOYSA-N 285619 N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >17200 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875367 378169258 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543880 Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24) VOILLODEUKMPEX-UHFFFAOYSA-N 285620 3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 25.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875402 378169259 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543881 Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24) VOILLODEUKMPEX-UHFFFAOYSA-N 285620 3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2620 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875402 378169259 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543884 Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2 PAISFAPTLJTHAX-UHFFFAOYSA-N 285621 US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 80.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700204 378169260 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543885 Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2 PAISFAPTLJTHAX-UHFFFAOYSA-N 285621 US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2250 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700204 378169260 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543888 Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25) RESYBSJMKXZFCE-UHFFFAOYSA-N 285622 3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 42.5 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875378 378169261 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543889 Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25) RESYBSJMKXZFCE-UHFFFAOYSA-N 285622 3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >1440 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875378 378169261 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543892 CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22) LVRAFMJECWTOEO-UHFFFAOYSA-N 285623 3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 134 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875371 378169262 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543893 CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22) LVRAFMJECWTOEO-UHFFFAOYSA-N 285623 3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4110 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875371 378169262 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543896 CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21) XVPMLCYXSAROSC-UHFFFAOYSA-N 285624 3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 65.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875407 378169263 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543897 CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21) XVPMLCYXSAROSC-UHFFFAOYSA-N 285624 3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5380 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875407 378169263 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543899 CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22) HRLMOSFOSQNGMI-UHFFFAOYSA-N 285625 3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 95::US10669279, Example 95::US9598421, Example 95 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 14800 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875368 378169264 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543902 CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23) IMOBPVDSTURWHO-UHFFFAOYSA-N 285626 3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 29.2 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875399 378169265 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543903 CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23) IMOBPVDSTURWHO-UHFFFAOYSA-N 285626 3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 908 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875399 378169265 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543906 CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24) VJEYWPJLEFUOTH-UHFFFAOYSA-N 285627 3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 20.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700205 378169266 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543907 CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24) VJEYWPJLEFUOTH-UHFFFAOYSA-N 285627 3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >1850 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700205 378169266 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543910 CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24) FKAXUOKPFFFYTF-UHFFFAOYSA-N 285628 3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 107 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700206 378169267 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543911 CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24) FKAXUOKPFFFYTF-UHFFFAOYSA-N 285628 3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3320 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700206 378169267 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543914 CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25) LCTMXACJLVAYNA-UHFFFAOYSA-N 285629 3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 138 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875366 378169268 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543915 CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25) LCTMXACJLVAYNA-UHFFFAOYSA-N 285629 3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1550 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875366 378169268 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543917 CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24) JMTGAAJHYHUEQI-UHFFFAOYSA-N 285630 3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 100::US10669279, Example 100::US9598421, Example 100 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 766 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700207 378169269 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543920 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1 InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25) LHIGSNUVLANYIO-UHFFFAOYSA-N 285631 3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1179 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875390 378169270 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543921 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1 InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25) LHIGSNUVLANYIO-UHFFFAOYSA-N 285631 3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >25900 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875390 378169270 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543924 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1 InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23) VFBYVKMGLDMLTI-UHFFFAOYSA-N 285632 3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 76.0 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700208 378169271 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543925 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1 InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23) VFBYVKMGLDMLTI-UHFFFAOYSA-N 285632 3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5010 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126700208 378169271 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543928 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1 InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24) XMHPQZNHOIRAHG-UHFFFAOYSA-N 285633 3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 203 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126703955 378169272 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543929 Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1 InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24) XMHPQZNHOIRAHG-UHFFFAOYSA-N 285633 3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1550 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 126703955 378169272 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543932 Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24) GYZISZRYVGZYRR-UHFFFAOYSA-N 285634 3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4.69 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875388 378169273 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 543933 Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1 InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24) GYZISZRYVGZYRR-UHFFFAOYSA-N 285634 3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 145 US Patent 10.7270/Q2P84DX5 aid1795686 US10077269 Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 118875388 378169273 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799084 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-7-11(13(19)6-9(12)8-20)14-15(16(24)21-10-2-3-10)22-23-4-1-5-25-17(14)23/h6-7,10H,1-5H2,(H,21,24) KEZOJFATBPGWGR-UHFFFAOYSA-N 399950 US10323042, Example 30::US10738063, Example 30 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >17900 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399950&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380499 405259984 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799086 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc(nc1)C#N InChI=1S/C16H15N5O2/c17-8-12-3-2-10(9-18-12)13-14(15(22)19-11-4-5-11)20-21-6-1-7-23-16(13)21/h2-3,9,11H,1,4-7H2,(H,19,22) WAMLUDBFCUDTPT-UHFFFAOYSA-N 399951 US10323042, Example 31::US10738063, Example 31 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399951&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380500 405259985 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799090 Clc1cccc(c1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-1-4-11(10-12)13-14(15(21)19-6-2-7-19)18-20-8-3-9-22-16(13)20/h1,4-5,10H,2-3,6-9H2 CRKMXHLUZCJURN-UHFFFAOYSA-N 399952 US10323042, Example 32::US10738063, Example 32 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >12200 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399952&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380505 405259986 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799094 Clc1cccc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-1-3-10(9-11)13-14(15(21)18-12-5-6-12)19-20-7-2-8-22-16(13)20/h1,3-4,9,12H,2,5-8H2,(H,18,21) GBWMEFKBLUNZIM-UHFFFAOYSA-N 399953 US10323042, Example 33::US10738063, Example 33 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >29000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399953&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380503 405259987 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799098 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C16H17ClFN3O2/c1-9(2)19-15(22)14-13(10-4-5-11(17)12(18)8-10)16-21(20-14)6-3-7-23-16/h4-5,8-9H,3,6-7H2,1-2H3,(H,19,22) SPFPGSNCBFECSG-UHFFFAOYSA-N 399954 US10323042, Example 34::US10738063, Example 34 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 18700 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399954&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380502 405259988 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799102 CNC(=O)c1nn2CCCOc2c1-c1ccc(Cl)c(F)c1 InChI=1S/C14H13ClFN3O2/c1-17-13(20)12-11(8-3-4-9(15)10(16)7-8)14-19(18-12)5-2-6-21-14/h3-4,7H,2,5-6H2,1H3,(H,17,20) KPTCNORYAGZPTM-UHFFFAOYSA-N 399955 US10323042, Example 35::US10738063, Example 35 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >23200 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399955&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380361 405259989 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799106 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(cc1C)C#N InChI=1S/C17H17FN4O2/c1-3-20-16(23)15-14(17-22(21-15)5-4-6-24-17)12-8-13(18)11(9-19)7-10(12)2/h7-8H,3-6H2,1-2H3,(H,20,23) GWWNXYAZKUJVBF-UHFFFAOYSA-N 399956 US10323042, Example 36::US10738063, Example 36 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >20700 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399956&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380362 405259990 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799110 CNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C15H15ClFN3O2/c1-8-6-10(16)11(17)7-9(8)12-13(14(21)18-2)19-20-4-3-5-22-15(12)20/h6-7H,3-5H2,1-2H3,(H,18,21) XWLDNGLNMIBYMP-UHFFFAOYSA-N 399957 US10323042, Example 37::US10738063, Example 37 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 11800 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399957&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380359 405259991 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799114 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1C InChI=1S/C16H17ClFN3O2/c1-3-19-15(22)14-13(16-21(20-14)5-4-6-23-16)10-8-12(18)11(17)7-9(10)2/h7-8H,3-6H2,1-2H3,(H,19,22) WYVVCFNADZMHEN-UHFFFAOYSA-N 399958 US10323042, Example 38::US10738063, Example 38 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3570 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399958&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380363 405259992 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799118 CCNC(=O)c1nn2CCCOc2c1-c1cc(F)c(Cl)cc1F InChI=1S/C15H14ClF2N3O2/c1-2-19-14(22)13-12(15-21(20-13)4-3-5-23-15)8-6-11(18)9(16)7-10(8)17/h6-7H,2-5H2,1H3,(H,19,22) MYPOVEUFNMJGML-UHFFFAOYSA-N 399959 US10323042, Example 39::US10738063, Example 39 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >29300 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399959&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380360 405259993 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799122 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)c(F)c1 InChI=1S/C16H14ClF2N3O2/c17-11-4-1-8(5-12(11)19)13-14(15(23)20-10-2-3-10)21-22-6-9(18)7-24-16(13)22/h1,4-5,9-10H,2-3,6-7H2,(H,20,23) MKFKTQOJJMIDOC-UHFFFAOYSA-N 399960 US10323042, Example 40::US10738063, Example 40 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2140 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399960&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380357 405259994 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799126 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-10-3-4-11(12(18)9-10)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AYWBPURWDSSBNA-UHFFFAOYSA-N 399961 US10323042, Example 41::US10738063, Example 41 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399961&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380576 405259995 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799130 Fc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-9-2-5-11(12(18)8-9)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) IFCNLIRUYVNPKA-UHFFFAOYSA-N 399962 US10323042, Example 42::US10738063, Example 42 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399962&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380577 405259996 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799134 FC1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22) NXQIEDDZYQXLGS-UHFFFAOYSA-N 399963 US10323042, Example 43::US10738063, Example 43 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >12600 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399963&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380579 405259997 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799138 Cc1cc(Cl)ccc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23) GRFHQTKEAOBDST-UHFFFAOYSA-N 399964 US10323042, Example 44::US10738063, Example 44 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6420 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399964&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380575 405259998 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799142 Fc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-8-9(2-5-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) LGFLTCBFNXDCLY-UHFFFAOYSA-N 399965 US10323042, Example 45::US10738063, Example 45 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 2210 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399965&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380578 405259999 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799146 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)NC2CC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-5-4-9(12(18)13(10)19)11-14(15(23)20-8-2-3-8)21-22-6-1-7-24-16(11)22/h4-5,8H,1-3,6-7H2,(H,20,23) FGOAWTXGIORNAM-UHFFFAOYSA-N 399966 US10323042, Example 46::US10738063, Example 46 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 11100 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399966&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380580 405260000 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799150 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)6-8(7-11(13)19)12-14(15(23)20-9-2-3-9)21-22-4-1-5-24-16(12)22/h6-7,9H,1-5H2,(H,20,23) ZDSSYIMMEPTDEO-UHFFFAOYSA-N 399967 US10323042, Example 47::US10738063, Example 47 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1670 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399967&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380510 405260001 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799154 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17ClFN3O2/c1-10-8-12(18)13(19)9-11(10)14-15(16(23)21-4-2-5-21)20-22-6-3-7-24-17(14)22/h8-9H,2-7H2,1H3 GUBLWTBQTNDNFO-UHFFFAOYSA-N 399968 US10323042, Example 48::US10738063, Example 48 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 706 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399968&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380508 405260002 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799158 Fc1cc(cc(F)c1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H14ClF2N3O2/c17-13-10(18)7-9(8-11(13)19)12-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(12)22/h7-8H,1-6H2 XUMPDYRHXWOEDT-UHFFFAOYSA-N 399969 US10323042, Example 49::US10738063, Example 49 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 1200 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399969&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380506 405260003 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799162 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1C#N InChI=1S/C17H14F2N4O2/c18-12-8-11(13(19)7-10(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 HIZORNOKOHJTBO-UHFFFAOYSA-N 399970 US10323042, Example 50::US10738063, Example 50 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 12500 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399970&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380511 405260004 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799166 Cc1cc(C#N)c(F)cc1-c1c(nn2CC(F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25) CICKNGAWODWCEX-UHFFFAOYSA-N 399971 US10323042, Example 51::US10738063, Example 51 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 558 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399971&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380512 405260005 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799170 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m1/s1 CICKNGAWODWCEX-LLVKDONJSA-N 399972 US10323042, Example 52::US10738063, Example 52 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >25000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399972&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380509 405260006 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799174 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 312 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799178 Cc1cc(C#N)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C18H16F2N4O2/c1-9-4-10(6-21)14(20)5-13(9)15-16(17(25)22-12-2-3-12)23-24-7-11(19)8-26-18(15)24/h4-5,11-12H,2-3,7-8H2,1H3,(H,22,25)/t11-/m0/s1 CICKNGAWODWCEX-NSHDSACASA-N 399973 US10323042, Example 53A::US10323042, Example 53B::US10738063, Example 53B Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 337 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399973&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380480 405260007 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799182 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m0/s1 NXQIEDDZYQXLGS-NSHDSACASA-N 399975 US10323042, Example 54::US10738063, Example 54 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 8250 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399975&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380481 405260008 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799186 F[C@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H15ClFN3O2/c17-10-3-1-9(2-4-10)13-14(15(22)19-12-5-6-12)20-21-7-11(18)8-23-16(13)21/h1-4,11-12H,5-8H2,(H,19,22)/t11-/m1/s1 NXQIEDDZYQXLGS-LLVKDONJSA-N 399976 US10323042, Example 55::US10738063, Example 55 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >23600 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399976&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380478 405260009 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799190 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m1/s1 DJQNRDCGWWXDHA-SECBINFHSA-N 399977 US10323042, Example 56::US10738063, Example 56 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 14600 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399977&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380479 405260010 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799194 Cc1cc(Cl)c(F)cc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-8-4-12(18)13(20)5-11(8)14-15(16(24)21-10-2-3-10)22-23-6-9(19)7-25-17(14)23/h4-5,9-10H,2-3,6-7H2,1H3,(H,21,24)/t9-/m0/s1 DJQNRDCGWWXDHA-VIFPVBQESA-N 399978 US10323042, Example 57::US10738063, Example 57 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 136 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399978&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 137497759 405260011 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799198 Fc1cc(-c2c3OCC(F)(F)Cn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H12ClF4N3O2/c17-9-4-10(18)8(3-11(9)19)12-13(14(25)22-7-1-2-7)23-24-5-16(20,21)6-26-15(12)24/h3-4,7H,1-2,5-6H2,(H,22,25) WSISMBBKFDPNKB-UHFFFAOYSA-N 399979 US10323042, Example 58 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 156 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399979&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380482 405260012 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799200 Clc1ccc(nc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C15H15ClN4O2/c16-9-2-5-11(17-8-9)12-13(14(21)18-10-3-4-10)19-20-6-1-7-22-15(12)20/h2,5,8,10H,1,3-4,6-7H2,(H,18,21) ZQOTYNLKFJDUAT-UHFFFAOYSA-N 399980 US10323042, Example 59::US10738063, Example 59 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399980&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380515 405260013 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799202 Cc1cncc(c1)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H18N4O2/c1-11-8-12(10-17-9-11)13-14(15(21)19-4-2-5-19)18-20-6-3-7-22-16(13)20/h8-10H,2-7H2,1H3 QSAFHZCASRDUOV-UHFFFAOYSA-N 399981 US10323042, Example 60::US10738063, Example 60 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399981&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380514 405260014 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799204 FC(F)(F)c1cncc(c1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15F3N4O2/c17-16(18,19)10-6-9(7-20-8-10)12-13(14(24)21-11-2-3-11)22-23-4-1-5-25-15(12)23/h6-8,11H,1-5H2,(H,21,24) BJUFTSVFKDFZEX-UHFFFAOYSA-N 399982 US10323042, Example 61::US10738063, Example 61 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399982&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380513 405260015 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799206 Cc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-3-4-12(10-19)9-14(11)15-16(17(23)20-13-5-6-13)21-22-7-2-8-24-18(15)22/h3-4,9,13H,2,5-8H2,1H3,(H,20,23) ZVWGRJASDAIIGJ-UHFFFAOYSA-N 399983 US10323042, Example 62::US10738063, Example 62 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399983&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380516 405260016 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799210 CC(C)NC(=O)c1nn2CCCOc2c1-c1ccc(cc1F)C#N InChI=1S/C17H17FN4O2/c1-10(2)20-16(23)15-14(17-22(21-15)6-3-7-24-17)12-5-4-11(9-19)8-13(12)18/h4-5,8,10H,3,6-7H2,1-2H3,(H,20,23) KKPVIUOWNKMGHX-UHFFFAOYSA-N 399984 US10323042, Example 63::US10738063, Example 63 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399984&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380457 405260017 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799214 CNC(=O)c1nn2CCCOc2c1-c1ccc(OC(F)F)nc1 InChI=1S/C14H14F2N4O3/c1-17-12(21)11-10(13-20(19-11)5-2-6-22-13)8-3-4-9(18-7-8)23-14(15)16/h3-4,7,14H,2,5-6H2,1H3,(H,17,21) AJJQMMGWFICENJ-UHFFFAOYSA-N 399985 US10323042, Example 64::US10738063, Example 64 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399985&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380456 405260018 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798972 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H18ClN3O2/c1-11-10-12(18)4-5-13(11)14-15(16(22)20-6-2-7-20)19-21-8-3-9-23-17(14)21/h4-5,10H,2-3,6-9H2,1H3 BLUWLSQGJDRYLP-UHFFFAOYSA-N 399921 Azetidin-1-yl[3-(4-chloro-2-methylphenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 1::US10738063, Example 1 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >29800 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399921&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366758 405259955 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798976 Cc1cc(Cl)ccc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H18ClN3O2/c1-10-9-11(18)3-6-13(10)14-15(16(22)19-12-4-5-12)20-21-7-2-8-23-17(14)21/h3,6,9,12H,2,4-5,7-8H2,1H3,(H,19,22) KXLPTRRQYABNIU-UHFFFAOYSA-N 399922 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 2::US10738063, Example 2 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >29500 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399922&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366752 405259956 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798980 Fc1cc(-c2c3OCCCn3nc2C(=O)N2CCC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-8-11(18)9(7-12(10)19)13-14(15(23)21-3-1-4-21)20-22-5-2-6-24-16(13)22/h7-8H,1-6H2 LTQPXIUEDFTWNR-UHFFFAOYSA-N 399923 Azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 3::US10738063, Example 3 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >15100 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399923&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366739 405259957 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798984 Fc1c(Cl)ccc(-c2c3OCCCn3nc2C(=O)N2CCC2)c1F InChI=1S/C16H14ClF2N3O2/c17-10-4-3-9(12(18)13(10)19)11-14(15(23)21-5-1-6-21)20-22-7-2-8-24-16(11)22/h3-4H,1-2,5-8H2 HGOQXTQGKPHGEY-UHFFFAOYSA-N 399924 Azetidin-1-yl[3-(4-chloro-2,3-difluorophenyl)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-yl]methanone ::US10323042, Example 4::US10738063, Example 4 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >17800 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399924&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366734 405259958 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798988 Cc1cc(C#N)c(F)cc1-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C18H17FN4O2/c1-10-7-11(9-20)14(19)8-13(10)15-16(17(24)21-12-3-4-12)22-23-5-2-6-25-18(15)23/h7-8,12H,2-6H2,1H3,(H,21,24) MJHYQMWSWMXYQH-UHFFFAOYSA-N 399925 3-(4-Cyano-5-fluoro-2-methylphenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 5::US10738063, Example 5 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >11900 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399925&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366740 405259959 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798992 Cc1cc(Cl)ccc1-c1c(nn2C[C@H](F)COc12)C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-6-10(18)2-5-13(9)14-15(16(23)20-12-3-4-12)21-22-7-11(19)8-24-17(14)22/h2,5-6,11-12H,3-4,7-8H2,1H3,(H,20,23)/t11-/m0/s1 GRFHQTKEAOBDST-NSHDSACASA-N 399926 (6S)-3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 6::US10738063, Example 6 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4700 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399926&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 137497758 405259960 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 798996 F[C@@H]1COc2c(c(nn2C1)C(=O)NC1CC1)-c1cc(F)c(Cl)cc1F InChI=1S/C16H13ClF3N3O2/c17-10-4-11(19)9(3-12(10)20)13-14(15(24)21-8-1-2-8)22-23-5-7(18)6-25-16(13)23/h3-4,7-8H,1-2,5-6H2,(H,21,24)/t7-/m0/s1 QMOPFHQOZKALTC-ZETCQYMHSA-N 399927 (6S)-3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropyl-6-fluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 7::US10738063, Example 7 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 306 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399927&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366728 405259961 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799000 Cc1cc(Cl)ccc1-c1c2OCC(F)(F)Cn2nc1C(=O)NC1CC1 InChI=1S/C17H16ClF2N3O2/c1-9-6-10(18)2-5-12(9)13-14(15(24)21-11-3-4-11)22-23-7-17(19,20)8-25-16(13)23/h2,5-6,11H,3-4,7-8H2,1H3,(H,21,24) RQKJDWFZSBVQSW-UHFFFAOYSA-N 399928 3-(4-Chloro-2-methylphenyl)-N-cyclopropyl-6,6-difluoro-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 8::US10738063, Example 8 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 974 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399928&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380356 405259962 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799004 CC1CCn2nc(C(=O)NC3CC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-21-17(23-10)14(11-2-4-12(18)5-3-11)15(20-21)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) GYVJFOZZFFIUSZ-UHFFFAOYSA-N 399929 3-(4-Chlorophenyl)-N-cyclopropyl-5-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 9::US10738063, Example 9 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 5090 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399929&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380526 405259963 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799008 CC1CCOc2c(c(nn12)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-10-8-9-23-17-14(11-2-4-12(18)5-3-11)15(20-21(10)17)16(22)19-13-6-7-13/h2-5,10,13H,6-9H2,1H3,(H,19,22) ZTEOJNWIHZBBMB-UHFFFAOYSA-N 399930 3-(4-Chlorophenyl)-N-cyclopropyl-7-methyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 10::US10738063, Example 10 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399930&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366732 405259964 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799012 Fc1cc(ccc1C#N)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H15FN4O2/c18-13-8-10(2-3-11(13)9-19)14-15(16(23)20-12-4-5-12)21-22-6-1-7-24-17(14)22/h2-3,8,12H,1,4-7H2,(H,20,23) RQCIGHZUMYJCCJ-UHFFFAOYSA-N 399931 3-(4-Cyano-3-fluorophenyl)-N-cyclopropyl-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide ::US10323042, Example 11::US10738063, Example 11 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399931&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130366747 405259965 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799016 Clc1ccc(cc1)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H16ClN3O2/c17-11-4-2-10(3-5-11)13-14(15(21)18-12-6-7-12)19-20-8-1-9-22-16(13)20/h2-5,12H,1,6-9H2,(H,18,21) NHVPCMGYIPONNR-UHFFFAOYSA-N 399932 US10323042, Example 12::US10738063, Example 12 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >29400 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399932&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380451 405259966 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799020 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15ClFN3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) TWKMZYIUVKFGDK-UHFFFAOYSA-N 399933 US10323042, Example 13::US10738063, Example 13 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >16400 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399933&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380450 405259967 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799022 Clc1ccc(cc1Cl)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H15Cl2N3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 OEWWVAVGPPIPRO-UHFFFAOYSA-N 399934 US10323042, Example 14::US10738063, Example 14 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 12700 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399934&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380453 405259968 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799026 Fc1cc(ccc1Cl)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C16H15ClFN3O2/c17-11-4-3-10(9-12(11)18)13-14(15(22)20-5-1-6-20)19-21-7-2-8-23-16(13)21/h3-4,9H,1-2,5-8H2 AQWXGANUJJZTGU-UHFFFAOYSA-N 399935 US10323042, Example 15::US10738063, Example 15 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >18300 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399935&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380527 405259969 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799030 Fc1cc(-c2c3OCCCn3nc2C(=O)NC2CC2)c(F)cc1Cl InChI=1S/C16H14ClF2N3O2/c17-10-7-11(18)9(6-12(10)19)13-14(15(23)20-8-2-3-8)21-22-4-1-5-24-16(13)22/h6-8H,1-5H2,(H,20,23) WYSBJUKHVQZOHC-UHFFFAOYSA-N 399936 US10323042, Example 16::US10738063, Example 16 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >6810 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399936&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380449 405259970 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799034 Cc1cc(Cl)c(F)cc1-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C17H17ClFN3O2/c1-9-7-12(18)13(19)8-11(9)14-15(16(23)20-10-3-4-10)21-22-5-2-6-24-17(14)22/h7-8,10H,2-6H2,1H3,(H,20,23) AIIYPFJZLRJGEL-UHFFFAOYSA-N 399937 US10323042, Example 17::US10738063, Example 17 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 4830 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399937&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380483 405259971 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799038 Cc1cc(C#N)c(F)cc1-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C18H17FN4O2/c1-11-8-12(10-20)14(19)9-13(11)15-16(17(24)22-4-2-5-22)21-23-6-3-7-25-18(15)23/h8-9H,2-7H2,1H3 HXVNESZNUYSKMT-UHFFFAOYSA-N 399938 US10323042, Example 18::US10738063, Example 18 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 6300 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399938&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380529 405259972 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799042 FC1(F)COc2c(c(nn2C1)C(=O)NC1CC1)-c1ccc(Cl)cc1 InChI=1S/C16H14ClF2N3O2/c17-10-3-1-9(2-4-10)12-13(14(23)20-11-5-6-11)21-22-7-16(18,19)8-24-15(12)22/h1-4,11H,5-8H2,(H,20,23) TUHZURBDZPBKQB-UHFFFAOYSA-N 399939 US10323042, Example 19 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) 3080 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399939&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 137497776 405259973 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799046 CC1CCn2nc(C(=O)N3CCC3)c(c2O1)-c1ccc(Cl)cc1 InChI=1S/C17H18ClN3O2/c1-11-7-10-21-17(23-11)14(12-3-5-13(18)6-4-12)15(19-21)16(22)20-8-2-9-20/h3-6,11H,2,7-10H2,1H3 MONOEYMRTNNARV-UHFFFAOYSA-N 399940 US10323042, Example 20::US10738063, Example 20 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399940&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380454 405259974 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799050 Clc1ccc(cc1Cl)-c1c2OCCCn2nc1C(=O)NC1CC1 InChI=1S/C16H15Cl2N3O2/c17-11-5-2-9(8-12(11)18)13-14(15(22)19-10-3-4-10)20-21-6-1-7-23-16(13)21/h2,5,8,10H,1,3-4,6-7H2,(H,19,22) XMTOCICLPIPODV-UHFFFAOYSA-N 399941 US10323042, Example 21::US10738063, Example 21 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >9700 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399941&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380455 405259975 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799054 Clc1ccc(cc1)-c1c(nn2CCCOc12)C(=O)N1CCC1 InChI=1S/C16H16ClN3O2/c17-12-5-3-11(4-6-12)13-14(15(21)19-7-1-8-19)18-20-9-2-10-22-16(13)20/h3-6H,1-2,7-10H2 BKTUIOVWODWFPG-UHFFFAOYSA-N 399942 US10323042, Example 22::US10738063, Example 22 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399942&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380473 405259976 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799058 Fc1cc(cc(F)c1C#N)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H14F2N4O2/c18-12-7-10(8-13(19)11(12)9-20)14-15(16(24)22-3-1-4-22)21-23-5-2-6-25-17(14)23/h7-8H,1-6H2 JVQZYDGQUZXTDQ-UHFFFAOYSA-N 399943 US10323042, Example 23::US10738063, Example 23 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >21400 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399943&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380477 405259977 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799062 COc1c(F)cc(cc1F)-c1c2OCCCn2nc1C(=O)N1CCC1 InChI=1S/C17H17F2N3O3/c1-24-15-11(18)8-10(9-12(15)19)13-14(16(23)21-4-2-5-21)20-22-6-3-7-25-17(13)22/h8-9H,2-7H2,1H3 ARADJHAPDWYDIE-UHFFFAOYSA-N 399944 US10323042, Example 24::US10738063, Example 24 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399944&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380471 405259978 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799066 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ncnn2c1 InChI=1S/C16H16N6O2/c23-15(19-11-3-4-11)14-13(16-21(20-14)6-1-7-24-16)10-2-5-12-17-9-18-22(12)8-10/h2,5,8-9,11H,1,3-4,6-7H2,(H,19,23) AEPRWSVYIWUKRK-UHFFFAOYSA-N 399945 US10323042, Example 25::US10738063, Example 25 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399945&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380475 405259979 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799070 Cc1cc(ccc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C18H18N4O2/c1-11-9-12(10-19)3-6-14(11)15-16(17(23)20-13-4-5-13)21-22-7-2-8-24-18(15)22/h3,6,9,13H,2,4-5,7-8H2,1H3,(H,20,23) MGICYBWWARAATG-UHFFFAOYSA-N 399946 US10323042, Example 26::US10738063, Example 26 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399946&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380476 405259980 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799074 FC(F)Oc1cc(ccn1)-c1c(nn2CCCOc12)C(=O)NC1CC1 InChI=1S/C16H16F2N4O3/c17-16(18)25-11-8-9(4-5-19-11)12-13(14(23)20-10-2-3-10)21-22-6-1-7-24-15(12)22/h4-5,8,10,16H,1-3,6-7H2,(H,20,23) MYBATSJXBUMOOH-UHFFFAOYSA-N 399947 US10323042, Example 27::US10738063, Example 27 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >12800 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399947&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380472 405259981 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799076 Fc1ccc(cc1-c1c2OCCCn2nc1C(=O)NC1CC1)C#N InChI=1S/C17H15FN4O2/c18-13-5-2-10(9-19)8-12(13)14-15(16(23)20-11-3-4-11)21-22-6-1-7-24-17(14)22/h2,5,8,11H,1,3-4,6-7H2,(H,20,23) QQMQNXMQOPTOHL-UHFFFAOYSA-N 399948 US10323042, Example 28::US10738063, Example 28 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399948&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380504 405259982 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 799080 O=C(NC1CC1)c1nn2CCCOc2c1-c1ccc2ccnn2c1 InChI=1S/C17H17N5O2/c23-16(19-12-3-4-12)15-14(17-21(20-15)8-1-9-24-17)11-2-5-13-6-7-18-22(13)10-11/h2,5-7,10,12H,1,3-4,8-9H2,(H,19,23) ONZFTFUFKHZXEF-UHFFFAOYSA-N 399949 US10323042, Example 29::US10738063, Example 29 Isoform 3 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (hPDE4D3) >30000 US Patent 10.7270/Q2NP26RH aid1799233 US10323042 Chappie, TA; Patel, NC; Verhoest, PR; Helal, CJ; Sciabola, S; LaChapelle, EA; Wager, TT; Hayward, MM Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=399949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=194&target=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=399949&enzyme=Isoform+3+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%28hPDE4D3%29&column=ki&startPg=0&Increment=50&submit=Search 130380501 405259983 1 MMHVNNFPFRRHSWICFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7